Sciclone Pharmaceuticals (SCLN) Discusses Steps Taken to Address Material Weaknesses in Internal Controls
Tweet Send to a Friend
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) brings investors attention to some important information regarding the significant and thorough remediation steps that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
